March Altus Capital Management

Latest statistics and disclosures from March Altus Capital Management's latest quarterly 13F-HR filing:

Portfolio Holdings for March Altus Capital Management

March Altus Capital Management holds 11 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Edwards Lifesciences (EW) 26.1 $4.2M +85% 35k 120.57
 View chart
ACADIA Pharmaceuticals (ACAD) 14.5 $2.3M -12% 73k 31.81
 View chart
Aratana Therapeutics 12.8 $2.0M 219k 9.36
 View chart
Johnson & Johnson (JNJ) 9.6 $1.5M 13k 118.15
 View chart
Dex (DXCM) 7.8 $1.2M +21% 14k 87.68
 View chart
Eli Lilly & Co. (LLY) 6.7 $1.1M -50% 13k 80.24
 View chart
Tesaro 6.3 $1.0M NEW 10k 100.20
 View chart
Zoetis Inc Cl A (ZTS) 5.2 $827k NEW 16k 52.01
 View chart
Biogen Idec (BIIB) 5.1 $814k NEW 2.6k 313.08
 View chart
Alexion Pharmaceuticals 4.8 $760k -27% 6.2k 122.60
 View chart
Regeneron Pharmaceuticals (REGN) 1.3 $201k NEW 500.00 402.00
 View chart

Past Filings by March Altus Capital Management

SEC 13F filings are viewable for March Altus Capital Management going back to 2013